The new corporate identity, Biohm Technologies, includes a fresh look and feel, representing a commitment to the advancement of microbiome innovation for the greater benefit of a wider consumer population.
Founded in 2016 by Afif Ghannoum and his father, Dr Mahmoud Ghannoum, one of the top microbiome researchers in the world, BIOHM Health initially focused on direct-to-consumer offerings revolving around its clinically studied and data-driven BIOHM FX probiotic formulation.
Dr Ghannoum’s research on the complex relationship between fungi and bacteria in the gut, fuelled in large part by the company’s at-home gut microbiome testing data, is the foundation for Biohm’s innovative solutions in probiotics.
“Biohm’s data innovation and resulting probiotic ingredient formulations are well positioned to serve a broader audience through a variety of channels, and that’s been the driving force behind our shift towards amplifying our B2B offerings,” said Sam Schatz, CEO of Biohm.
The entry of Biohm Technologies into an increased B2B focus includes the rebranding of the company’s flagship probiotic blend, originally known as BIOHM FX, now marketed as Mycohsa.
Additionally, the company offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space looking to provide their customers with greater opportunities to build value and customer intimacy, all powered by Biohm Technologies.
The new brand identity will be unveiled as Biohm Technologies makes its first appearance as an exhibitor at SupplySide West in October, with a booth in the new exhibitor section of the show floor.
Biohm Technologies, based in Cleveland, OH, US specialises in the development of targeted microbiome products leveraging the company’s extensive dataset of bacterial and fungal populations in the gut, a departure from the industry's predominant focus on bacteria alone.
Biohm’s data-driven methodology, called Symbiont, is the basis for the creation of award-winning ingredients validated through clinical trials.
The company’s flagship ingredient is Mycohsa, the first data-powered probiotic blend clinically shown to break down digestive biofilms and support optimal levels of both bacteria and yeasts for gut health.
Biohm Technologies also offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space.
